Educational purposes only. Not investment advice. Past performance does not guarantee future results. View full terms

BIIB

Biogen Inc. β€’ Healthcare (#8 of 11)

$196.58
-2.09 (-1.05%)
View:
Close:$196.58
Vol:EXTREME(95%ile)
Ratio:1.64x
|
RSI:52(Neutral)
MACD:↓
β‰₯75%25-75%<25%
Vol.%
Sector Rotation
2026-06-18(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRAL
β–²1 Upβ–Ό0 Down3 Hold
Jun 18Morgan Stanley
–Equal-Weight
Jun 15Mizuho
–Outperform
Jun 8Needham
β–²Hold β†’ Buy
May 27RBC Capital
–Outperform
Price Targets
NEUTRAL
β–²2 Raisesβ–Ό1 Lowers+5.5% avg
Jun 18Morgan Stanley
$206β†’$224+8.7%
Jun 15Mizuho
$236β†’$221-6.4%
Jun 8Needham
$255New
May 27RBC Capital
$222β†’$227+2.3%
Trade Setup
ATR-based
Entry$196.58
Target$208.70 (+6.2%)
Stop$187.49
R/R1.33
Risk-4.6%
ATR$6.06

Simple setup: 1.5x ATR stop, 2x ATR target

Risk Metrics
Sharpe (20d)
2.10Excellent
Volatility (20d)
29.3%Normal
Beta (60d)
0.03Defensive
Alpha (20d)
+3.7%Moderate+
News Analysis
EN
δΈ­
ν•œ
ζ—₯

No analysis record found.